The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland January 30, 2020. REUTERS
BERLIN, March 3 (Reuters) – Swiss pharmaceutical company Roche is aiming for a double-digit market share in the weight loss market and wants to close the gap on its Danish rival Novo Nordisk its CEO told Germany’s Handelsblatt business daily.
“We expect to be among the top three in the market at the very least,” Roche Chief Executive Thomas Schinecker said in an interview with the newspaper published on Tuesday.
Writing by Linda Pasquini; Editing by Christopher Cushing
